What is the efficacy of surgical pleurodesis in the prevention of pneumothorax recurrence?

Updated: Apr 28, 2020
  • Author: Brian J Daley, MD, MBA, FACS, FCCP, CNSC; Chief Editor: Mary C Mancini, MD, PhD, MMM  more...
  • Print

A patient treated with surgical pleurodesis has a recurrence prevention rate of greater than 90%. Talc is the preferred agent for pleurodesis, and it can be administered by insufflation or as a slurry. Practice variation depends on local practitioner experience, resources, and success with approaches ranging from VATS (recommended by the American College of Chest Physicians [ACCP]) [39] to surgical thoracotomy and pleurectomy (recommended by the British Thoracic Society [BTS] because of the absolute lowest recurrence rates). [38]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!